CoreWeave (CRWV) stock today: Credit agreement amendment puts liquidity covenant in focus after Friday surge
4 January 2026
2 mins read

CoreWeave (CRWV) stock today: Credit agreement amendment puts liquidity covenant in focus after Friday surge

NEW YORK, January 3, 2026, 20:10 ET — Market closed

  • CoreWeave disclosed an amendment to its DDTL 3.0 credit agreement, easing minimum liquidity and delaying some covenant tests. 1
  • Shares last closed up 10.77% at $79.32 on Friday, after trading between $73.16 and $81.17. 2
  • Next catalysts include the amendment exhibit in the coming Form 10-K and an estimated Feb. 9 earnings window on Nasdaq’s calendar. 3

CoreWeave, Inc. said it amended a credit agreement tied to its DDTL 3.0 facility, a regulatory filing showed. 1

Shares of the AI cloud provider closed Friday up 10.77% at $79.32, data showed. 2

The amendment lands as investors weigh how quickly debt-heavy AI infrastructure companies can keep adding capacity without tripping lender safeguards. Covenants — rules inside loan documents that require cash levels or financial ratios — can force a borrower to raise funding or curb spending if it falls short.

DDTL stands for delayed-draw term loan, which lets a borrower take down funding over time rather than all at once. CoreWeave said the change was meant to align the facility with the timing of deliveries discussed on its earnings call for the quarter ended Sept. 30, 2025. 3

The amendment, signed on Dec. 31, changes the DDTL 3.0 credit agreement originally dated July 28, 2025, with MUFG Bank as administrative agent and U.S. Bank among the counterparties, the filing said. It cuts the minimum liquidity amount (cash and other readily available funds) for monthly payment dates ending on and after March 1, 2026 and prior to May 1, 2026 to $100 million, and postpones the first tests of the debt service coverage ratio — a cashflow-to-debt-payment metric — until Oct. 31, 2027 and the contract realization ratio until Feb. 28, 2026. CoreWeave said it can use an unlimited number of “equity cures” — equity injections to remedy a covenant breach — until Oct. 28, 2026, subject to limits after that. 4

Broader U.S. equities were mixed on Friday, with the Nasdaq easing while the S&P 500 and Dow finished higher as traders watched bond yields and the Federal Reserve outlook. CoreWeave outperformed that tape.

CoreWeave has leaned on capital markets to fund rapid buildouts of AI data-center capacity. In December it priced an upsized $2.25 billion offering of 1.75% convertible senior notes due 2031, according to a company statement. Convertible notes are debt that can convert into shares, potentially diluting existing holders. 5

Debt has become a flashpoint for skeptics. “They have to keep borrowing more and more because they spend more money than they can get,” D.A. Davidson analyst Gil Luria told The Verge. 6

CoreWeave trimmed its annual revenue forecast in November after data center partner delays, Reuters reported, sharpening investor focus on delivery schedules and financing needs.

Before the next session, investors will look for the full amendment text in CoreWeave’s annual report, which the company said would include it as an exhibit. Nasdaq’s earnings calendar listed Feb. 9 as an estimated report date, though companies often confirm dates closer to the release. 3

Technicians will watch whether the stock can hold Friday’s breakout above the prior close around $71.61. The shares traded between $73.16 and $81.17 and changed hands in a volume of about 30 million shares. 7

Macro data could set the tone for high-growth AI names next week, with investors watching the U.S. jobs report due on Jan. 9 for clues on rates and risk appetite, a Reuters column said.

For CoreWeave, the immediate question is whether covenant breathing room and delivery timing translate into steadier cash metrics once markets reopen. Any further funding moves or customer capacity updates are likely to keep the stock volatile.

Stock Market Today

Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
Costco closed Friday up 1.2% at $1,001.16, regaining the $1,000 level as about 2.36 million shares changed hands. January net sales rose 9.3% to $21.33 billion, with comparable sales up 7.1% and online sales surging 34.4%. Wells Fargo raised its price target to $950, maintaining a neutral rating. The next earnings call is set for March 5.
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus
Previous Story

Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus

Liquidia (LQDA) stock slides after heavy $30 put bets—what investors are watching next
Next Story

Liquidia (LQDA) stock slides after heavy $30 put bets—what investors are watching next

Go toTop